Aerospace Medicine · Supplementary · from Aerospace Medicine

Case 3: Circadian Disruption in Commercial Airline Crew

Patient Presentation

Demographics: 51-year-old female senior commercial airline captain (Boeing 787, international long-haul routes)

Chief Complaint: "I can't sleep properly anymore, I'm exhausted all the time, and I nearly missed a critical callout on approach last week."

History of Present Illness: Captain L.H. presents to the aviation medical examiner for her annual Class 1 medical certificate renewal. Over the past 8 months, she has been experiencing progressively worsening insomnia, excessive daytime somnolence, and cognitive difficulties she attributes to her international route schedule. She typically flies transmeridian routes crossing 8-12 time zones (North America to Asia-Pacific) with layovers of 24-36 hours before return flights.

She reports difficulty initiating sleep at layover destinations (sleep onset latency of 90-120 minutes), frequent nocturnal awakenings, and non-restorative sleep averaging 3-4 hours per sleep period. She has been using over-the-counter diphenhydramine (50 mg) nightly during layovers, which provides sedation but leaves her feeling cognitively impaired the following morning. She has also increased her caffeine intake to 6-8 cups of coffee per day.

Her husband reports that she has become increasingly irritable, has gained approximately 8 kg over the past year, and occasionally appears disoriented upon awakening at home. She endorses depressed mood, decreased libido, and two episodes of near-microsleep during cruise phase of flight in the past month, the second of which resulted in delayed response to an ATC callout that was caught by her first officer.

Past Medical History:

• Mild gastroesophageal reflux disease (GERD)
• Pre-diabetes (HbA1c 5.9% on last check, 14 months ago)
• No prior psychiatric history

Medications:

• Omeprazole 20 mg daily
• Diphenhydramine 50 mg PRN (nightly during layovers)
• Melatonin 5 mg PRN (inconsistent use, reports variable efficacy)

Social History:

• Non-smoker; social alcohol (2-3 glasses wine per week, never within 8 hours of duty)
• 28 years of commercial aviation experience, 14 years as captain
• Married, two adult children
• Minimal regular exercise due to fatigue and schedule constraints
• Average monthly flight hours: 85-90 (near regulatory maximum)

Family History:

• Mother: type 2 diabetes, breast cancer (age 62)
• Father: hypertension, coronary artery disease (CABG age 64)

Physical Examination

• Vital Signs: BP 142/88 mmHg, HR 82 bpm, RR 14, SpO2 97% on room air, Temp 36.7°C, BMI 29.4 kg/m²
• General: Appears fatigued with periorbital darkening; oriented but mildly psychomotor slowed
• HEENT: Mallampati Class III airway; no thyromegaly
• Cardiovascular: Regular rate and rhythm, no murmurs; bilateral lower extremity trace edema
• Abdomen: Soft, non-tender, central adiposity
• Neurological: Alert and oriented x4; cranial nerves intact; mild difficulty with serial 7s and digit span (backward) compared to prior assessments
• Psychiatric: PHQ-9 score: 12 (moderate depression); Epworth Sleepiness Scale: 16 (severe excessive daytime sleepiness); GAD-7: 8 (mild anxiety)

Workup and Results

Laboratory Studies:

Imaging/Additional Studies:

• Polysomnography: Sleep efficiency 62%, prolonged sleep onset latency (45 min), reduced REM sleep (12% of total sleep time), no obstructive sleep apnea (AHI 3.2/hr)
• Actigraphy (14-day): Severely fragmented sleep-wake pattern with no consistent circadian rhythm; average total sleep time 4.8 hours/24-hour period
• Psychomotor Vigilance Task (PVT): Mean reaction time 342 ms (impaired; baseline 241 ms); 8 lapses per 10-minute test (significant impairment)
• Continuous glucose monitoring (7-day): Postprandial spikes to 195 mg/dL, time in range (70-140) only 58%

Clinical Image

Diagram showing the disruption of the circadian melatonin-cortisol axis in transmeridian flight crew, with comparison of normal vs. disrupted sleep-wake cycles and metabolic consequences. Source: Educational illustration.

Diagnosis

Circadian Rhythm Sleep-Wake Disorder, Shift Work/Jet Lag Type (Chronic) with Secondary Metabolic Syndrome and Subclinical Hypothyroidism

Key Diagnostic Criteria:

• Chronic insomnia and excessive sleepiness temporally associated with recurring transmeridian flight schedule
• Objective evidence of circadian disruption: suppressed evening melatonin, elevated morning cortisol, fragmented actigraphy pattern
• Functional impairment: cognitive deficits on PVT, near-microsleep episodes during flight operations
• Metabolic consequences: progression from pre-diabetes to diabetes (HbA1c 6.3%), dyslipidemia, weight gain, elevated TSH
• Duration exceeding 3 months with significant occupational and personal impairment

Treatment Plan

1. Immediate aeromedical action: Temporary removal from international long-haul routes; reassignment to domestic short-haul schedule pending stabilization
2. Sleep hygiene and circadian realignment:

• Strategic timed light exposure (10,000 lux light box, 30 min at destination morning)
• Timed melatonin: 0.5 mg (low-dose) taken 5 hours before desired bedtime at destination
• Discontinue diphenhydramine (anticholinergic burden, cognitive impairment, not FAA-approved)

1. Pharmacological (aviation-compatible):

• Melatonin 0.5 mg as above (acceptable to most civil aviation authorities with restrictions)
• Consider ramelteon 8 mg if melatonin insufficient (requires FAA HIMS review)

1. Metabolic management:

• Endocrinology referral for new diabetes diagnosis and subclinical hypothyroidism
• Metformin 500 mg BID with titration
• Vitamin D3 2,000 IU daily
• Dietary counseling focused on glycemic control and anti-inflammatory nutrition
• Structured exercise program: 150 min/week moderate aerobic activity

1. Mental health support:

• Cognitive behavioral therapy for insomnia (CBT-I), 6-session program
• Psychiatry evaluation for moderate depression (PHQ-9: 12); may require SSRI with FAA reporting

1. Follow-up: Repeat PVT, actigraphy, and metabolic labs at 3 months; Class 1 medical certificate decision pending treatment response

Key Learning Points

• Chronic circadian disruption in aviation personnel is an occupational hazard with cumulative health consequences including metabolic syndrome, cardiovascular disease, depression, and cancer (IARC classifies shift work involving circadian disruption as Group 2A — probably carcinogenic)
• The suprachiasmatic nucleus can only adjust by approximately 1-1.5 hours per day, making rapid transmeridian travel inherently disruptive; eastward travel is typically more difficult than westward
• Diphenhydramine and other first-generation antihistamines, while sedating, impair cognitive function for 12+ hours and are incompatible with aviation duty; they do not promote restorative sleep architecture
• Low-dose melatonin (0.3-0.5 mg) is more effective as a chronobiotic than high-dose (5-10 mg) formulations, which cause supraphysiologic levels and can worsen circadian disruption
• Aeromedical decision-making must balance the pilot's health, career, and public safety; fatigue-related performance decrements pose unacceptable risk to flight safety and require prompt intervention

All cases for this lecture as Markdown